CSIMarket
 


Celularity Inc   (CELU)
Other Ticker:  
 
 

CELU's Revenue Growth by Quarter and Year

Celularity Inc 's Revenue results by quarter and year




CELU Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 4.13 -10.62 0.00
III Quarter September 3.79 4.14 10.62 0.00
II Quarter June 2.94 3.78 0.00 0.00
I Quarter March 3.94 5.94 0.00 0.00
FY   10.67 17.99 0.00 0.00



CELU Revenue third quarter 2023 Y/Y Growth Comment
Celularity Inc reported decrease in Revenue in the third quarter 2023 by -8.55% to $ 3.79 millions, from the same quarter in 2022.
Despite modest results in the third quarter 2023, contraction in Celularity Inc 's Revenue appears to be smaller than Company's recent average decline.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 171 other companies have achieved higher Revenue growth. While Celularity Inc ' s Revenue decline of -8.55% ranks overall at the positon no. 2775 in the third quarter 2023.




CELU Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September -8.55 % -61.02 % - -
II Quarter June -22.22 % - - -
I Quarter March -33.67 % - - -
FY   - - - -

Financial Statements
Celularity Inc 's third quarter 2023 Revenue $ 3.79 millions CELU's Income Statement
Celularity Inc 's third quarter 2022 Revenue $ 4.14 millions Quarterly CELU's Income Statement
New: More CELU's historic Revenue Growth >>


CELU Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -0.24 % - -
III Quarter September 28.78 % 9.52 % - -
II Quarter June -25.38 % -36.36 % - -
I Quarter March -4.6 % - - -
FY (Year on Year)   - - - -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #172
Healthcare Sector #451
Overall #2775

Revenue Y/Y Growth Statistics
High Average Low
-8.44 % -31.35 % -61.07 %
(Sep 30 2023)   (Sep 30 2022)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #172
Healthcare Sector #451
Overall #2775
Revenue Y/Y Growth Statistics
High Average Low
-8.44 % -31.35 % -61.07 %
(Sep 30 2023)   (Sep 30 2022)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Celularity Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
28.86 % -4.7 % -36.38 %
(Sep 30 2023)  


CELU's III. Quarter Q/Q Revenue Comment
Celularity Inc achieved in the III. Quarter 2023 above company average sequential Revenue jump of 28.78%, to $ 3.79 millions, from $2.94 millions in the second quarter.
CELU is impressively improving, not only claiming higher then average growth, and also accelerating speed.

Within Major Pharmaceutical Preparations industry 62 other companies have achieved higher Revenue quarter on quarter growth. While Celularity Inc 's Revenue growth quarter on quarter, overall rank is 362.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #63
Healthcare Sector #128
Overall #362
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #63
Healthcare Sector #128
Overall #362
Revenue Q/Q Growth Statistics
High Average Low
28.86 % -4.7 % -36.38 %
(Sep 30 2023)  


CELU's III. Quarter Q/Q Revenue Comment
Celularity Inc achieved in the III. Quarter 2023 above company average sequential Revenue jump of 28.78%, to $ 3.79 millions, from $2.94 millions in the second quarter.
CELU is impressively improving, not just recording better then normal growth, and also improving rate.

Within Major Pharmaceutical Preparations industry 62 other companies have achieved higher Revenue quarter on quarter growth. While Celularity Inc 's Revenue growth quarter on quarter, overall rank is 362.


Celularity Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 14.79 $ 15.14 $ 15.98 $ 17.98 $ 3.22
Y / Y Revenue Growth (TTM) 358.68 % 55.87 % - - -
Year on Year Revenue Growth Overall Ranking # 365 # 373 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -2.31 % -5.25 % -11.13 % 457.54 % -66.8 %
Seq. Revenue Growth (TTM) Overall Ranking # 3635 # 3108 # 3209 # 3109 # 3636




Cumulative Revenue growth Comment
With 358.68% annual Revenue growth, Celularity Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2023.

In the Healthcare sector 118 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 365, from total ranking in previous quarter at 373.

Revenue TTM Q/Q Growth Statistics
High Average Low
358.68 %
207.28 %
55.87 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 199
Healthcare Sector # 119
Overall # 365

Revenue TTM Y/Y Growth Statistics
High Average Low
358.68 %
207.28 %
55.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 199
Sector # 541
S&P 500 # 3635
Cumulative Revenue growth Comment
With 358.68% annual Revenue growth, Celularity Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2023.

In the Healthcare sector 118 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 365, from total ranking in previous quarter at 373.

Revenue TTM Q/Q Growth Statistics
High Average Low
358.68 %
207.28 %
55.87 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 199
Healthcare Sector # 119
Overall # 365

Revenue TTM Y/Y Growth Statistics
High Average Low
358.68 %
207.28 %
55.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 199
Sector # 541
S&P 500 # 3635




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CELU's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CELU's Competitors
Revenue Growth for Celularity Inc 's Suppliers
Revenue Growth for CELU's Customers

You may also want to know
CELU's Annual Growth Rates CELU's Profitability Ratios CELU's Asset Turnover Ratio CELU's Dividend Growth
CELU's Roe CELU's Valuation Ratios CELU's Financial Strength Ratios CELU's Dividend Payout Ratio
CELU's Roa CELU's Inventory Turnover Ratio CELU's Growth Rates CELU's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Procyon Corporation-0.22%$ -0.221 millions
Amedisys Inc-0.31%$ -0.314 millions
Karyopharm Therapeutics Inc -0.38%$ -0.376 millions
Establishment Labs Holdings Inc -0.50%$ -0.505 millions
Opko Health Inc -0.64%$ -0.639 millions
Integra Lifesciences Holdings Corp-0.72%$ -0.719 millions
Healthcare Services Group Inc -0.75%$ -0.748 millions
Phibro Animal Health Corporation-0.77%$ -0.772 millions
Bionexus Gene Lab Corp -0.83%$ -0.831 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Prestige Consumer Healthcare Inc -1.12%$ -1.125 millions
Sharecare Inc -1.13%$ -1.127 millions
Lifevantage Corp-1.14%$ -1.140 millions
Organon and Co -1.17%$ -1.171 millions
Optinose Inc -1.27%$ -1.270 millions
Baxter International Inc -1.72%$ -1.723 millions
Puma Biotechnology Inc -1.73%$ -1.727 millions
Blueprint Medicines Corporation-1.76%$ -1.763 millions
Standard Biotools Inc -1.92%$ -1.918 millions
Pacira Biosciences inc -2.11%$ -2.114 millions
Bristol myers Squibb Company-2.25%$ -2.246 millions
Aurinia Pharmaceuticals Inc -2.27%$ -2.266 millions
Abbott Laboratories-2.56%$ -2.565 millions
Enhabit Inc -2.79%$ -2.785 millions
Novocure Limited-2.81%$ -2.807 millions
Uniqure N v -2.90%$ -2.899 millions
Vaso Corporation-2.92%$ -2.925 millions
Scientific Industries Inc -3.16%$ -3.165 millions
Akumin Inc -3.21%$ -3.205 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com